GRAIL, Inc. (GRAL)

↓ Download CSV

CIK 0001699031 · Nasdaq · Services-Medical Laboratories

  • Sector Services
  • Incorporated DE
  • Fiscal year ends Dec 31

In fiscal 2025, GRAIL, Inc. reported revenue of $147.17M, up 17.2% from the prior year. The company ran a net loss, with a net margin of -277.5%. It held $2.92B in total assets against $344.15M in total liabilities.

Key ratios (FY2025)

-382.0%
Operating margin
-277.5%
Net margin
-15.8%
Return on equity
+17.2%
Revenue growth (YoY)
Metric (FY)202520242023
Revenue$147.17M$125.59M$93.11M
Operating Income-$562.16M-$2.19B-$1.52B
Net Income-$408.35M-$2.03B-$1.47B
EPS (Diluted)$-11.11$-63.54$-47.21
Total Assets$2.92B$2.98B$3.91B
Total Liabilities$344.15M$479.90M$267.63M
Shareholders' Equity$2.58B$2.50B
Cash & Equivalents$249.73M$214.23M$97.29M
Operating Cash Flow-$299.01M-$577.16M-$595.80M
Capital Expenditures$909.0K$5.21M$12.89M
Shares Outstanding36.75M31.90M31.05M